SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008895
Filing Date
2017-05-05
Accepted
2017-05-04 18:43:49
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20170331.htm 10-Q 1448421
2 EX-31.1 rare-ex311_6.htm EX-31.1 17409
3 EX-31.2 rare-ex312_7.htm EX-31.2 17487
4 EX-32.1 rare-ex321_8.htm EX-32.1 10795
5 GRAPHIC g201705042026520524542.jpg GRAPHIC 45311
  Complete submission text file 0001564590-17-008895.txt   4366688

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rare-20170331.xml EX-101.INS 846976
7 XBRL TAXONOMY EXTENSION SCHEMA rare-20170331.xsd EX-101.SCH 32335
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20170331_cal.xml EX-101.CAL 33820
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20170331_def.xml EX-101.DEF 88603
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20170331_lab.xml EX-101.LAB 233933
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20170331_pre.xml EX-101.PRE 169212
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 17815638
SIC: 2834 Pharmaceutical Preparations